Hydrochloric Acid → (S)-3-(4-(5-methyl-1H-tetrazol-1-yl)phenoxy)-1-(piperidin-4-yl)pyrrolidin-2-one hydrochloride salt
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([N:14]2[CH2:18][CH2:17][CH:16]([O:19][C:20]3[CH:25]=[CH:24][C:23]([N:26]4[C:30]([CH3:31])=[N:29][N:28]=[N:27]4)=[CH:22][CH:21]=3)[C:15]2=[O:32])[CH2:10][CH2:9]1)=O)(C)(C)C.[ClH:33]>C(Cl)Cl.O1CCOCC1>[ClH:33].[CH3:31][C:30]1[N:26]([C:23]2[CH:22]=[CH:21][C:20]([O:19][C@H:16]3[CH2:17][CH2:18][N:14]([CH:11]4[CH2:10][CH2:9][NH:8][CH2:13][CH2:12]4)[C:15]3=[O:32])=[CH:25][CH:24]=2)[N:27]=[N:28][N:29]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of tert-butyl-4-(3-(4-(5-methyl-1H-tetrazol-1-yl)phenoxy)-2-oxopyrrolidin-1-yl)piperidine-1-carboxylate (621 mg, 1.4 mmol) in DCM (15 mL) was added excess 4N HCl in dioxane (5 mL). The reaction was stirred for 4 hours and then concentrated in vacuo to yield (S)-3-(4-(5-methyl-1H-tetrazol-1-yl)phenoxy)-1-(piperidin-4-yl)pyrrolidin-2-one hydrochloride salt (501 mg, 94%) as an off white solid, which was used without any further purification.
Workup
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-7a3839bf94fe40818d0710eb822da421
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08754226B2
Reaction notes
Loading…